Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Friedreich's Ataxia
Biotech
After pair of failures, PTC finds path for Friedreich ataxia med
PTC has managed to slash through the regulatory jungle to find a path forward for a Friedreich ataxia med after a pair of failures last year.
Annalee Armstrong
Mar 1, 2024 9:20am
FDA demands data on 2 PTC candidates, delaying filing
Oct 27, 2023 7:30am
Design rethinks lead drug, causing delay and steep stock drop
Aug 15, 2023 8:50am
PTC plots path to rare disease approval despite phase 3 fail
May 24, 2023 6:20am
FDA scraps AdComm for Reata's rare disease candidate
Oct 14, 2022 9:30am
Solid Bio hopes to fortify itself after absorbing AavantiBio
Sep 30, 2022 10:30am